XENIOS Platform

One platform enabling complementary next-generation therapies for lung and heart failures, because the heart and the lungs are linked anatomically. No other company except XENIOS AG is offering lung and heart therapies on one single platform.

XENIOS Platform

One platform enabling complementary next-generation therapies for lung and heart failures, because the heart and the lungs are linked anatomically. No other company except XENIOS AG is offering lung and heart therapies on one single platform.

XENIOS Clinical Support

Our internationally acclaimed Clinical Support team supports the clinical application of all novalung, medos & i-cor products. Specialists trained in intensive care are available 24 hours a day, 7 days a week on a telephone hotline. The Clinical Support team also provides support on-site in hospitals during initial applications of novalung products.

XENIOS Clinical Support

Our internationally acclaimed Clinical Support team supports the clinical application of all novalung, medos & i-cor products. Specialists trained in intensive care are available 24 hours a day, 7 days a week on a telephone hotline. The Clinical Support team also provides support on-site in hospitals during initial applications of novalung products.

XENIOS Campus

The XENIOS CAMPUS launched in spring 2016 is a platform provided by XENIOS AG which enables you to undertake individual advanced training. The XENIOS CAMPUS enables XENIOS AG to offer its partners, staff and users a global digital network which combines all the benefits of an integrative learning management system. The XENIOS CAMPUS is an open community with members and partners all over the world.

XENIOS Campus

The Xenios Campus is a platform provided by Xenios AG which enables you to undertake individual advanced training. The Xenios Campus is based on the integrated learning concept of “blended learning”. Modern didactic methods have been used to combine traditional forms of teaching such as seminars and courses.